Clinical Trial Update: Vaccine Therapy in Treating Patients With Melanoma of the Eye [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of a vaccine therapy for intraocular melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Intraocular Melanoma | Phase 3 | Status: TERMINATED